Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)

View source ↗

Summary

FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clobetasol Propionate Ointment USP, 0.05% (Clobetasol Propionate)

Snippet

ORIG AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE OINTMENT USP, 0.05%)